Penicillin desensitization: correlation of clinical and immunological events using an in vitro model

Authors

  • SHERWIN A. GILLMAN,

    1. Pediatric Allergy and Immunology Division, Los Angeles County-University of Southern California Medical Center, Los Angeles, California, U.S.A.
    Search for more papers by this author
  • JOEL L. KOROTZER,

    1. Pediatric Allergy and Immunology Division, Los Angeles County-University of Southern California Medical Center, Los Angeles, California, U.S.A.
    Search for more papers by this author
  • ZACK H. HADDAD

    Corresponding author
    1. Pediatric Allergy and Immunology Division, Los Angeles County-University of Southern California Medical Center, Los Angeles, California, U.S.A.
    Search for more papers by this author

Dr Zack H. Haddad, Gen. Lab. 1G38, Los Angeles County USC Med. Ctr., 1200 North State Street, Los Angeles, California 90033, U.S.A.

Summary

A patient with actinomycosis was found to have immediate hypersensitivity to penicillin by previously described skin testing methods as well as by a recently described in vitro system utilizing rat peritoneal mast cells. Desensitization to penicillin became imperative, but in using the classical route (the intracutaneous route), systemic anaphylaxis and other complications were encountered. Subsequently, successful desensitization was accomplished utilizing the intravenous route. We are able to demonstrate this patient's loss of reactivity to penicillin by the rat mast cell system as well as skin tests and to correlate the immunological state with the clinical course.

Ancillary